Haemonetics Income Statement
HAE / Health Care|15 years of annual SEC 10-K data (FY2012-FY2026)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Haemonetics reported $1.3B in revenue and $118M in net income for FY2026. Revenue has grown at a 2.8% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
| Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.4B | $1.3B | $1.2B | $993.2M | - | - | - | $225.4M | $886.1M | $908.8M | $910.4M | $938.5M | $892.0M |
| Cost of Revenue | $617.5M | $546.4M | $611.9M | $617.5M | $553.6M | $487.7M | $472.6M | $504.0M | $550.0M | $492.0M | $507.6M | $502.9M | $476.0M | $470.1M | $463.9M |
| Gross Profit | $691.5M | $787.6M | $749.0M | $691.5M | $615.1M | $505.5M | $397.8M | $484.5M | $417.5M | $411.9M | $378.5M | $405.9M | $434.4M | $468.4M | $428.1M |
| SG&A Expense | $429.8M | $442.4M | $436.8M | $431.8M | $376.7M | $340.1M | $275.2M | $282.0M | $273.5M | $316.5M | $301.7M | $317.2M | $337.2M | $366.0M | $323.1M |
| R&D Expense | $54.4M | $59.8M | $62.7M | $54.4M | $50.1M | $46.8M | $32.9M | $30.9M | $35.7M | $39.2M | $37.6M | $45.0M | $54.2M | $54.2M | $44.4M |
| Operating Income | $164.9M | $156.7M | $221.8M | $164.9M | $156.0M | $80.8M | $89.7M | $103.4M | $83.5M | $56.2M | -$19.4M | -$43.9M | $40.5M | $46.4M | $56.4M |
| Interest Expense | $19.5M | $19.3M | $35.9M | $19.5M | $13.0M | $5.8M | $9.4M | $13.5M | $12.6M | $7.7M | - | - | - | - | - |
| Income Tax | $34.3M | $30.7M | $44.4M | $34.3M | $26.0M | $20.3M | -$6.6M | $10.6M | $18.6M | $14.1M | -$1.2M | $2.2M | $14.3M | $1.3M | $11.1M |
| Net Income | $117.6M | $167.7M | $117.6M | $117.6M | $115.4M | $43.4M | $79.5M | $76.5M | $55.0M | $45.6M | -$26.3M | -$55.6M | $16.9M | $35.1M | $38.8M |
| EPS (Basic) | $2.32 | $2.06 | $3.33 | $2.32 | $2.27 | $0.85 | $1.57 | $1.51 | -$1.09 | $0.33 | $0.68 | $0.76 | $0.33 | $1.32 | $1.59 |
| EPS (Diluted) | $2.29 | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 | $1.55 | $1.48 | -$1.09 | $0.32 | $0.67 | $0.74 | $0.32 | $1.30 | $1.56 |
| Shares Outstanding | 48.2M | 48.2M | 50.8M | 51.4M | 51.4M | 51.4M | 51.3M | 51.8M | 52.3M | 50.9M | 51.7M | 52.0M | 52.1M | 51.0M | 50.6M |
| Gross Margin | 52.8% | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% | - | - | - | 182.8% | 42.7% | 44.7% | 47.7% | 49.9% | 48.0% |
| Operating Margin | 12.6% | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | - | - | - | 24.9% | -2.2% | -4.8% | 4.5% | 5.0% | 6.3% |
| Profit Margin | 9.0% | 12.6% | 8.6% | 9.0% | 9.9% | 4.4% | - | - | - | 20.2% | -3.0% | -6.1% | 1.9% | 3.8% | 4.3% |